Activate Now
 
ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Patient Insights into the Design of Technology to Support a Strengths-Based Approach to Health Care.

Greater intake of dietary omega-3 fatty acids associated with lower risk of diabetic retinopathy

SURVEY: Weight Management & Chronic Illness

Japanese green tea consumers have reduced risk of dementia

Researchers find herpes strain in the nervous system

Do Nothing, Accomplish Everything! The Connection Between Breathing and Healing

Nature Heals

Choline: Why You Should Eat Your Egg Yolks and Take Krill

Calcium, vitamin D supplementation associated improved stroke recovery

Best Herbs to Help With Insomnia

 
Print Page
Email Article

Ampligen Trials for Chronic Fatigue Syndrome Expanded

  [ 32 votes ]   [ Discuss This Article ]
By Sources: PR Newswire, Philadelphia, PA. April 8, 1 • www.ProHealth.com • April 8, 1999


Hemispherx Receives FDA Approval To Expand CFS Program - Number of Patients More Than Double in Cost-Recovery Treatment

Hemispherx Biopharma, Inc. today [April 8, 1999] said that it has received authorization from the Food and Drug Administration (FDA) to more than double the number of patients undergoing treatment in its cost-recovery program for Chronic Fatigue Syndrome (CFS).

In the first quarter, Hemispherx announced that active treatment of patients in a confirmatory Phase III clinical trial of its drug Ampligen® was underway in a 40-week protocol that involved placebo-controlled, double-blind testing.

Today's announcement concerns the parallel clinical activity in the U.S. in which now more than 100 patients suffering from severely debilitating CFS will pay for Ampligen® to be used during the clinical program. The company said that a key part of its drug development strategy has been to use various incentives that the FDA has made available to Hemispherx, including this cost recovery program.

With the new FDA authorization, it is estimated that more than 200 patients with CFS, which is also known as Myalgic Encephalomyelitis (ME) in Europe, are involved in the combined programs. Patients are currently being evaluated in San Diego/Los Angeles/Irvine/San Francisco Bay, California; Incline Village, Nevada; Tulsa, Oklahoma; Miami/Hollywood, Florida; Chicago; Salt Lake City; Charlotte, North Carolina; Philadelphia/Delaware Valley region, Pennsylvania; Montgomery, Alabama; Washington, D.C.; New York City and three sites in the New York City/Long Island/Northern New Jersey area. These sites represent the top CFS/ME investigators in the United States.

Hemispherx, which is based in Philadelphia, also has offices in Brussels, Belgium, and antiviral drug development facilities in Rockville, Maryland. At the end of last year, Hemispherx Biopharma Europe, a subsidiary company, filed a full marketing application in Brussels and London that covers the 15-country membership in the European Union. The Company also has said that additional applications for full marketing approval in other countries are expected, based on clinical results to date.

Patients not eligible for the Phase III confirmatory trial in the U.S. may seek treatment under the expanded treatment protocol administered by Hemispherx and Olsten Health Services, a subsidiary of Olsten Corporation. Timely information can be obtained on a Hotline at 888-559-4623, managed by Olsten Health Care.

To the company's knowledge, Hemispherx is the only company with authorized Phase III studies in the U.S. for CFS and the only company with a pending application for full marketing approval in any major pharmaceutical market world-wide. The Centers for Disease Control estimates that CFS affects approximately 500,000 Americans and various medical studies suggest a similar number of Europeans are affected as well.

Hemispherx Biopharma is a pharmaceutical company engaged in the manufacture and global clinical development of new drug entities in the nucleic acid (NA) class for chronic viral diseases and disorders of the immune system including CFS, hepatitis B and hepatitis C.

Information contained in this news release, other than historical information, should be considered forward-looking and is subject to various risk factors and uncertainties. For instance, the strategies and operations of Hemispherx involve risks of competition, changing market conditions, changes in laws and regulations affecting these industries and numerous other factors discussed in this release and in the company's filings with the Securities and Exchange Commission. Accordingly, actual results may differ materially from those in any forward-looking statements.

Sources:
PR Newswire, Philadelphia, PA. April 8, 1999.



Post a Comment

Featured Products From the ProHealth Store
Optimized Curcumin Longvida® Vitamin D3 Extreme™ Ultra ATP+, Double Strength

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%

Natural Remedies

Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging
Are You Obtaining the Proper Enzymes? Are You Obtaining the Proper Enzymes?
Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
Block Acid Reflux to Prevent Esophageal Problems! Block Acid Reflux to Prevent Esophageal Problems!
Everything You Always Wanted to Know About Sleep But Were Too Tired to Ask Everything You Always Wanted to Know About Sleep But Were Too Tired to Ask

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE AND SAVE 15% NOW*
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map